Melanoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Melanoma stocks.

Melanoma Stocks Recent News

Date Stock Title
Aug 1 IOVA Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Aug 1 AGEN Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Aug 1 GALT Galectin Therapeutics appoints Khurram Jamil as chief medical officer
Aug 1 GALT Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer
Jul 31 AGEN Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
Jul 31 IOVA Bullish Iovance Biotherapeutics Insiders Loaded Up On US$74.9m Of Stock
Jul 31 IOVA Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
Jul 30 IOVA Iovance Biotherapeutics: A Lot To Unpack
Jul 30 GALT Galectin Therapeutics Inc.'s (NASDAQ:GALT) largest shareholders are retail investors with 57% ownership, insiders own 20%
Jul 30 EVAX EVAX: Initiating Coverage of Evaxion
Jul 29 IOVA Why Iovance Biotherapeutics Stock Stumbled Today
Jul 29 IOVA Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
Jul 29 IOVA Iovance Biotherapeutics downgraded to Neutral at Piper Sandler, stock falls
Jul 29 IOVA Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2
Jul 28 IOVA ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Jul 26 AGEN The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
Jul 26 AGEN Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update
Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

Browse All Tags